Trial Profile
A Study to Compare the Efficacy of Pemetrexed Maintenance Therapy with Conservative Surveillance in Patients with Advanced Stage Non Small Cell Lung Cancer (NS-NSCLC) With No Disease Progression after Induction with Platin and Pemetrexed
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Jan 2016 New trial record